Erik D'hondt

7 Patents

• US125952972026

  Methods and Compositions for Inhibition of EGF/EGFR Pathway in Combination with Tyrosine Kinase Inhibitors

  In3bio Ltd.

  0 cites
• US125707082026

  Recombinant Proteins and Their Therapeutic Uses

  0 cites
• US124339392025

  Self-assembling Synthetic Proteins Comprising Cholera Toxin Beta Subunit

  In3bio Ltd.

  0 cites
• US122572452025

  Methods and Compositions for Inhibition of EGF/EGFR Pathway in Combination with Anaplastic Lymphoma Kinase Inhibitors

  In3bio Ltd.

  0 cites
• US122583892025

  Methods and Compositions for Inhibition of EGF/EGFR Pathway in Combination with Tyrosine Kinase Inhibitors

  In3bio Ltd.

  0 cites
• US121346622024

  Synthetic Proteins and Therapeutic Uses Thereof

  In3bio Ltd.

  0 cites
• US120309202024

  Recombinant Proteins and Their Therapeutic Uses

  In3bio Ltd.

  0 cites